Interact to see
Advertisement
Advertisement
BALSX vs NLSCX
BALSX vs NLSCX Comparison
Open Charts BALSX vs NLSCX
BlackRock U.S. Insights Lon/Shr Eq Inv A
Price$10.23
Change-$0.06 (-0.58%)
VolumeN/A
Net Assets12.8M
Neuberger Berman Long Short C
Price$18.69
Change-$0.09 (-0.48%)
VolumeN/A
Net Assets8.01B
BALSX vs NLSCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 8.01B vs. BALSX (12.8M). BALSX (0.00) and NLSCX (0.00) have matching dividends . BALSX was incepted earlier than NLSCX: BALSX (2 years) vs NLSCX (14 years). BALSX (4.20) is less costly to investors than NLSCX (2.43). BALSX is a more actively managed with annual turnover of: 313.00 vs. NLSCX (48.00). BALSX (1000) and NLSCX (1000) have matching initial minimum investment requirements. NLSCX annual gain was more profitable for investors over the last year : 7.31 vs. BALSX (5.90).
| BALSX | NLSCX | BALSX / NLSCX | |
| Total Expense Ratio | 1.86 | 2.43 | 77% |
| Annual Report Gross Expense Ratio | 4.20 | 2.43 | 173% |
| Fund Existence | 2 years | 14 years | - |
| Gain YTD | 8.830 | 6.162 | 143% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 12.8M | 8.01B | 0% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 5.90 | 7.31 | 81% |
| Returns for 3 years | N/A | 17.97 | - |
| Returns for 5 years | N/A | 15.86 | - |
| Returns for 10 years | N/A | 44.60 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PZINX | 13.28 | N/A | N/A |
| Pzena International Value Instl | |||
| FIFAX | 27.36 | -0.02 | -0.07% |
| American Funds Income Fund of Amer F3 | |||
| FEFRX | 31.65 | -0.13 | -0.41% |
| First Eagle Rising Dividend Fund R6 | |||
| THLCX | 24.49 | -0.34 | -1.37% |
| Thrivent Large Cap Growth S | |||
| WBIRX | 30.97 | -0.63 | -1.99% |
| William Blair International Growth R6 | |||